Scientific article

Modulation de l'immunité chez le patient cancéreux: une arme à double tranchant?

Other titleModulation of immunity in cancerous patient : an weapon with double edges?
Published inRevue médicale de la Suisse romande, vol. 122, no. 7, p. 325-328
Publication date2002-07

Nutritional support of cancer patients should ideally contribute to improve the immune defence, maintain the protein body pool and sensitize the tumour to oncologic treatments. Such a goal is not easy to achieve, because any nutritional support efficient at stimulating immune response and protein syntheses might also simultaneously stimulate the tumour growth. Contradictory observations have been reported for several nutrients contained in the nutritive solutions available on the market. This is the case for glutamine, arginine, omega-3 fatty acids and nucleotides. Their clinical use during oncologic therapies deserves further testing and analysis.

  • Animals
  • Arginine / administration & dosage
  • Fatty Acids, Omega-3 / administration & dosage
  • Glutamine / administration & dosage
  • Humans
  • Neoplasms / immunology
  • Neoplasms / therapy
  • Nucleotides / administration & dosage
  • Treatment Outcome
  • Réponseimmune
  • Nutrition
  • Nucléotides
  • Glutamine
  • Arginine
  • Acides gras polyinsaturés
  • Cancer
Research group
Citation (ISO format)
DUPERTUIS, Yves Marc et al. Modulation de l’immunité chez le patient cancéreux: une arme à double tranchant? In: Revue médicale de la Suisse romande, 2002, vol. 122, n° 7, p. 325–328.
Main files (1)
Article (Published version)
ISSN of the journal0035-3655

Technical informations

Creation04/07/2022 9:16:00 PM
First validation04/07/2022 9:16:00 PM
Update time03/16/2023 10:48:31 AM
Status update03/16/2023 10:48:31 AM
Last indexation01/17/2024 11:06:08 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack